The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose tumors have specific type of genetic mutation called KRAS G12C. It is…
Month: May 2021
FDA Approves Rybrevant for Certain Patients with Non-Small Cell Lung Cancer
Lung cancer is a complex disease, accounting for almost 25% of all cancer deaths. The Food and Drug Administration (FDA) has approved Rybrevant for treatment of adults with non-small cell lung cancer…
Study: New Breath Test to Detect Lung Cancer
Lung cancer is the second most commonly diagnosed cancers. According to the World Health Organization, there were 2.2 million new lung cancer cases and 1.8 million people died from the disease in…
Topotecan–Berzosertib Combination Effective for SCLC Treatment
Researchers all over the world are continuously been working towards finding effective treatments and therapies for lung cancer. There are widely two types of lung cancer: small cell lung cancer (SCLC) and…
Genetic Testing for Lung Cancer – Why is It Important?
Genetic mutations play an important role in the development of lung cancer. Genetic testing helps in identifying specific genetic changes in the tumor cells that might be get treated with targeted therapies….